![John B. Hawken](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John B. Hawken
Directeur Général chez
Immutep SAS
Profil
John B. Hawken is currently the Co-Chief Executive Officer at Immutep SAS since 2010.
Previously, he worked as a Principal at Aptanomics SA. He completed his undergraduate degree at the University of Oxford and holds an MBA from INSEAD.
Postes actifs de John B. Hawken
| Sociétés | Poste | Début |
|---|---|---|
Immutep SAS
 Immutep SAS Pharmaceuticals: MajorHealth Technology Develops T-cell response-based immuno therapeutics for the treatment of cancer and infectious diseases | Directeur Général | 02/12/2003 |
Anciens postes connus de John B. Hawken
| Sociétés | Poste | Fin |
|---|---|---|
Aptanomics SA
 Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Corporate Officer/Principal | - |
Formation de John B. Hawken
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Develops T-cell response-based immuno therapeutics for the treatment of cancer and infectious diseases | Health Technology |
